Paper Details
- Home
- Paper Details
Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity.
Author: BagnascoM, BertoliniC, CanonicaG W, CiprandiG, GrögenJ, MelaG S, PassalacquaG, PronzatoC, RiccaV, VareseP
Original Abstract of the Article :
BACKGROUND: It is well known that allergen-specific nasal challenge (ASNC) is a fruitful tool with which to evaluate antiallergic activity exerted by a drug. Azelastine is a new antihistamine also available in topical form (i.e., nasal spray). OBJECTIVE: The aim of the study was to evaluate the eff...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/s0091-6749(96)80196-5
データ提供:米国国立医学図書館(NLM)
Azelastine Nasal Spray: A Promising Treatment for Allergic Rhinitis
The field of allergic rhinitis research is always seeking new and effective treatments to alleviate the symptoms of this common condition. This study investigates the effects of azelastine nasal spray, an antihistamine, on inflammatory changes in the nasal mucosa following allergen-specific nasal challenge (ASNC).
The researchers conducted a double-blind, placebo-controlled, randomized study involving 20 patients with pollen allergy. The patients were exposed to ASNC at baseline and after one week of treatment with either azelastine or placebo. The study focused on evaluating the effects of azelastine on clinical symptoms, cytologic assessment of nasal cells, mediator levels, and expression of intercellular adhesion molecule-1 (ICAM-1) on nasal epithelial cells.
Azelastine's Anti-Allergic Effects
The results showed that azelastine significantly reduced total symptom score, eosinophilic and neutrophilic infiltration, and ICAM-1 expression during both early- and late-phase reactions to ASNC. These findings suggest that azelastine effectively inhibits the inflammatory processes associated with allergic rhinitis, demonstrating its potential as a treatment for this condition.
Easing the Burden of Allergic Rhinitis
This study provides valuable information for clinicians and patients seeking relief from allergic rhinitis. Azelastine nasal spray appears to be a promising treatment option, effectively reducing symptoms and inflammation. Think of it this way: just as a camel adapts to the dry desert air by using its nostrils effectively, azelastine helps those with allergic rhinitis navigate the challenges of a stuffy nose and other uncomfortable symptoms.
Dr. Camel's Conclusion
This study highlights the potential of azelastine nasal spray as a safe and effective treatment for allergic rhinitis. Its ability to reduce symptoms and inflammation suggests a promising approach to managing this common condition.
Date :
- Date Completed 1997-01-22
- Date Revised 2019-07-23
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.